Form 4: Cyanotech Director Michael Davis Increases Stake in Company
SEC Form 4
Director Michael Davis reports purchasing additional shares of Cyanotech Corp through a revocable trust.
Summary
- On September 23 and 24, 2024, Michael Davis, a director and 10% owner of Cyanotech Corporation, acquired 5,000 shares each day at prices of $0.77 and $0.73 respectively.
- These purchases were made under a pre-arranged 10b5-1(c) plan adopted on March 6, 2024.
- Following these transactions, Davis beneficially owns 1,440,440 shares through a revocable trust, along with other shares held directly, by his spouse, and through other trusts.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It reflects insider buying, which can be seen as positive, but it's a routine transaction under a pre-existing plan.
Positives
- The director's purchase of shares could be interpreted as a positive signal about the company's prospects.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common among publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company.
Stakeholder Impact
- The increased stake of a director could improve investor confidence.
Key Dates
| Date | Description |
|---|---|
| 03-06-2024 | Adoption date of the 10b5-1(c) plan |
| 09/23/2024 | Date of first reported transaction: purchase of 5,000 shares at $0.77 |
| 09/24/2024 | Date of second reported transaction: purchase of 5,000 shares at $0.73 |
| 09/25/2024 | Date of signature on the Form 4 filing |
Keywords
Cyanotech, Michael Davis, Director, Share Purchase, Form 4, Beneficial Ownership, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.